Please use this identifier to cite or link to this item:
http://hdl.handle.net/1843/47139
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Caroline Amaral Machado | pt_BR |
dc.creator | Ana Cristina Simões e Silva | pt_BR |
dc.creator | Amanda Silva de Miranda | pt_BR |
dc.creator | Thiago Macedo e Cordeiro | pt_BR |
dc.creator | Rodrigo Novaes Ferreira | pt_BR |
dc.creator | Leonardo Cruz de Souza | pt_BR |
dc.creator | Antônio Lúcio Teixeira | pt_BR |
dc.creator | Aline Silva de Miranda | pt_BR |
dc.date.accessioned | 2022-11-10T19:07:48Z | - |
dc.date.available | 2022-11-10T19:07:48Z | - |
dc.date.issued | 2020 | - |
dc.citation.volume | 27 | pt_BR |
dc.citation.issue | 32 | pt_BR |
dc.citation.spage | 5374 | pt_BR |
dc.citation.epage | 5402 | pt_BR |
dc.identifier.doi | http://dx.doi.org/10.2174/0929867326666190710173234 | pt_BR |
dc.identifier.issn | 1875-533X | pt_BR |
dc.identifier.uri | http://hdl.handle.net/1843/47139 | - |
dc.description.resumo | Traumatic Brain Injury (TBI) is a major public health problem. It is the leading cause of death and disability, especially among children and young adults. The neurobiology basis underlying TBI pathophysiology remains to be fully revealed. Over the past years, emerging evidence has supported the hypothesis that TBI is an inflammatory based condition, paving the way for the development of potential therapeutic targets. There is no treatment capable to prevent or minimize TBI associated outcomes. Therefore, the search for effective therapies is a priority goal. In this context, animal models have become valuable tools to study molecular and cellular mechanisms involved in TBI pathogenesis as well as novel treatments. Herein, we discuss therapeutic strategies to treat TBI focused on immunomodulatory and/or anti-inflammatory approaches in the pre-clinical setting. | pt_BR |
dc.description.sponsorship | CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico | pt_BR |
dc.description.sponsorship | FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais | pt_BR |
dc.description.sponsorship | CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior | pt_BR |
dc.language | eng | pt_BR |
dc.publisher | Universidade Federal de Minas Gerais | pt_BR |
dc.publisher.country | Brasil | pt_BR |
dc.publisher.department | ICB - DEPARTAMENTO DE MORFOLOGIA | pt_BR |
dc.publisher.department | ICX - DEPARTAMENTO DE QUÍMICA | pt_BR |
dc.publisher.department | MED - DEPARTAMENTO DE CLÍNICA MÉDICA | pt_BR |
dc.publisher.initials | UFMG | pt_BR |
dc.relation.ispartof | Current Medicinal Chemistry | pt_BR |
dc.rights | Acesso Restrito | pt_BR |
dc.subject | Traumatic brain injury | pt_BR |
dc.subject | Inflammation | pt_BR |
dc.subject | Treatment | pt_BR |
dc.subject | Immunomodulatory agents | pt_BR |
dc.subject | Anti-inflammatory | pt_BR |
dc.subject | Pathogenesis | pt_BR |
dc.subject.other | Cérebro | pt_BR |
dc.subject.other | Ferimentos e lesões | pt_BR |
dc.subject.other | Inflamação | pt_BR |
dc.subject.other | Agentes antiinflamatórios | pt_BR |
dc.title | Immune-based therapies for traumatic brain injury: insights from pre-clinical studies | pt_BR |
dc.type | Artigo de Periódico | pt_BR |
dc.url.externa | https://www.eurekaselect.com/article/99547 | pt_BR |
dc.identifier.orcid | https://orcid.org/0000-0003-0586-0483 | pt_BR |
dc.identifier.orcid | https://orcid.org/0000-0001-9222-3882 | pt_BR |
dc.identifier.orcid | https://orcid.org/0000-0002-8887-2772 | pt_BR |
dc.identifier.orcid | https://orcid.org/0000-0003-4933-6309 | pt_BR |
dc.identifier.orcid | https://orcid.org/0000-0002-5987-8622 | pt_BR |
dc.identifier.orcid | https://orcid.org/0000-0001-5027-9722 | pt_BR |
dc.identifier.orcid | https://orcid.org/0000-0002-9621-5422 | pt_BR |
dc.identifier.orcid | https://orcid.org/0000-0003-2811-7924 | pt_BR |
Appears in Collections: | Artigo de Periódico |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.